These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2273458)

  • 1. Marked heterogeneity in the intrahepatic distribution of quinidine in rats: implications in pharmacokinetics.
    Lee HJ; Chiou WL
    J Pharm Sci; 1990 Sep; 79(9):778-81. PubMed ID: 2273458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic distribution of hydrochlorothiazide and quinidine in rats: implications in pharmacokinetics.
    AbdelHameed MH; Chen TM; Chiou WL
    J Pharm Sci; 1993 Oct; 82(10):992-6. PubMed ID: 8254499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
    Booth CL; Brouwer KR; Brouwer KL
    Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of malaria infection on the disposition of quinine and quinidine in the rat isolated perfused liver preparation.
    Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
    J Pharm Pharmacol; 1990 Jun; 42(6):428-32. PubMed ID: 1979624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinine impairs quinidine clearance in rat perfused liver.
    Mihaly GW; Scott H; Hyman MK; Morgan DJ; Smallwood RA
    J Pharm Pharmacol; 1993 Mar; 45(3):215-7. PubMed ID: 8097780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cimetidine on quinidine distribution and tissue pH in rats.
    Shibasaki S; Kawamata Y; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1989 Jun; 12(6):324-31. PubMed ID: 2778625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
    Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
    J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of pharmacokinetic interaction between propranolol and quinidine in rats.
    Yamada K; Yasuhara M; Yatsuzuka A; Okumura K; Sakurai T; Kawai C; Hori R
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1876-9. PubMed ID: 1394707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.
    Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):425-40. PubMed ID: 4087170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fever on quinine and quinidine disposition in the rat.
    Mansor SM; Ward SA; Edwards G
    J Pharm Pharmacol; 1991 Oct; 43(10):705-8. PubMed ID: 1682445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of pharmacokinetic interaction between ajmaline and quinidine in rats.
    Yamada K; Yatsuzuka A; Yasuhara M; Okumura K; Hori R; Sakurai T; Kawai C
    J Pharmacobiodyn; 1986 Apr; 9(4):347-51. PubMed ID: 3735057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic interaction between quinidine and digoxin: role of inhibition of sinusoidal Na⁺/K⁺ ATPase digoxin binding.
    Li P; Weiss M; Roberts MS
    Eur J Pharm Sci; 2012 Sep; 47(2):506-11. PubMed ID: 22820029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay.
    Lau YY; Wu CY; Okochi H; Benet LZ
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1040-5. PubMed ID: 14634033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of quinidine.
    Fattinger K; Vozeh S; Ha HR; Borner M; Follath F
    Br J Clin Pharmacol; 1991 Mar; 31(3):279-86. PubMed ID: 2054269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin quinidine interaction: a pharmacokinetic study in the isolated perfused rat liver.
    Ben-Itzhak J; Bassan HM; Shor R; Lanir A
    Life Sci; 1985 Aug; 37(5):411-5. PubMed ID: 4021722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies.
    Venkatesh G; Ramanathan S; Mansor SM; Nair NK; Sattar MA; Croft SL; Navaratnam V
    J Pharm Biomed Anal; 2007 Mar; 43(4):1546-51. PubMed ID: 17157469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinidine-induced rise in ajmaline plasma concentration.
    Hori R; Okumura K; Inui K; Yasuhara M; Yamada K; Sakurai T; Kawai C
    J Pharm Pharmacol; 1984 Mar; 36(3):202-4. PubMed ID: 6144760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-dependent exsorption of quinidine in the rat intestine.
    Bair CH; Tang MJ; Huang JD
    J Pharm Pharmacol; 1992 Aug; 44(8):659-62. PubMed ID: 1359090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary excretion of berberine.
    Tsai PL; Tsai TH
    Drug Metab Dispos; 2004 Apr; 32(4):405-12. PubMed ID: 15039293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.